Cite

HARVARD Citation

    Giaccone, G. et al. (n.d.). A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer. European journal of cancer. 51 (16), pp. 2321-2329. [Online]. 
  
Back to record